InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,270.13
(
-0.69%
)
US TECH 100
18,122.80
(
-0.58%
)
Dow Jones
39,098.33
(
-1.44%
)
Brent Oil
81.22
(
-0.38%
)
Bitcoin
67,097.18
(
-2.90%
)
Post# of 54
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

max2205

Send PM Follow Ignore
Followers 40
Posts 34652
Boards Moderated 2
Alias Born 06/26/2007

max2205

Re: None

Thursday, 10/30/2008 10:36:46 AM

Thursday, October 30, 2008 10:36:46 AM

Post# of 54
On 10/21/08 Lev Pharmaceuticals, Inc. was acquired by ViroPharma Incorporated, a biotechnology focused on developing and commercializing new medicines to treat serious diseases, including Clostridium difficile, hereditary angioedema (HAE), and cytomegalovirus (CMV). The Lev Pharmaceuticals website will no longer be edited or updated, effective immediately. However, patients can still register to receive additional information regarding HAE by clicking on the Register Now button on this website.

To learn more about ViroPharma, its clinical and commercial pipeline, hereditary angioedema, and the status of Cinryze C1 Inhibitor (human), please CLICK HERE.

SEND LAWYERS! GUNS! AND MONEY!...THE SHIT HAS HIT THE FAN
Visit 20% Sharp Shooters Board http://investorshub.advfn.com/boards/board.asp?board_id=10729

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up